Comorbilidades y uso previo de antibióticos en pacientes adultos hospitalizados con infección por Acinetobacter sp. resistente a carbapenems
Descripción del Articulo
Objective: The objective was to determine the frequency of comorbidities and the previous use of antibiotics in adult patients hospitalized with Acinetobacter sp. resistant to carbapenems. Material and methods: Observational and descriptive study, in adult patients hospitalized with Acinetobacter sp...
Autor: | |
---|---|
Formato: | tesis de grado |
Fecha de Publicación: | 2020 |
Institución: | Universidad Nacional de Trujillo |
Repositorio: | UNITRU-Tesis |
Lenguaje: | español |
OAI Identifier: | oai:dspace.unitru.edu.pe:20.500.14414/15508 |
Enlace del recurso: | https://hdl.handle.net/20.500.14414/15508 |
Nivel de acceso: | acceso abierto |
Materia: | Acinetobacter sp Resistencia Carbapenems Comorbilidades Antibióticos Hospitalizados |
Sumario: | Objective: The objective was to determine the frequency of comorbidities and the previous use of antibiotics in adult patients hospitalized with Acinetobacter sp. resistant to carbapenems. Material and methods: Observational and descriptive study, in adult patients hospitalized with Acinetobacter sp infection in the internal medicine service and ICU of the Regional Teaching Hospital of Trujillo during the 2011-2017 period; The frequency of comorbidities (diabetes mellitus, arterial hypertension and chronic kidney disease) and the previous use of antibiotics (carbapenems, aminoglycosides, quinolones, 3rd and 2nd generation cephalosporins, vancomycin, metronidazole and ampicillin-sulbactam) were determined in these patients and then, their association was analyzed using chi-square. Results: The sample was 33 patients; where A. baumannii was the only species found, with 30 resistant strains and 3 susceptible to carbapenems. The majority were males (63.6%), an average age of 53.5 ± 6.9 years was obtained and only a significant difference was evidenced for the previous use of carbapenems (p = 0.036). Conclusion: The majority presented at least one comorbidity and previously used at least one antibiotic; mainly in the group with infection with ABRC. |
---|
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).